Piotr Rutkowski

Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KIT mutations and expression

Krzysztof Goryca, Tymon Rubel, Jerzy Ostrowski, 2009, BMC Cancer.

Combined Nivolumab and Ipilimumab or Monotherapy in Previously Untreated Melanoma

J. Larkin, P. Rutkowski, R. Gonzalez, 2017 .

Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

Dirk Schadendorf, Peter Mohr, Reinhard Dummer, 2012 .

Surgery of Primary Melanomas

P. Rutkowski, Z. Nowecki, Piotr Rutkowski, 2010, Cancers.

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Dirk Schadendorf, Reinhard Dummer, Paolo A Ascierto, 2015, The New England journal of medicine.

Increased cancer risk of heterozygotes with NBS1 germline mutations in poland

Karl Sperling, Raymonda Varon, Galina Maneva, 2004, International journal of cancer.

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.

Dirk Schadendorf, Axel Hauschild, Antoni Ribas, 2019, European journal of cancer.